Immunoprecise Antibodies Stock Price on September 11, 2024
| IPA Stock | USD 0.41 0.03 7.89% |
Below is the normalized historical share price chart for Immunoprecise Antibodies extending back to January 07, 2002. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Immunoprecise Antibodies stands at 0.41, as last reported on the 27th of November, with the highest price reaching 0.42 and the lowest price hitting 0.38 during the day.
If you're considering investing in Immunoprecise Stock, it is important to understand the factors that can impact its price. Immunoprecise Antibodies holds Efficiency (Sharpe) Ratio of -0.11, which attests that the entity had a -0.11% return per unit of risk over the last 3 months. Immunoprecise Antibodies exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Immunoprecise Antibodies' Market Risk Adjusted Performance of 0.6199, standard deviation of 6.59, and Risk Adjusted Performance of (0.08) to validate the risk estimate we provide.
At present, Immunoprecise Antibodies' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 26.9 M, whereas Other Stockholder Equity is forecasted to decline to about 9.3 M. . As of November 27, 2024, Price To Sales Ratio is expected to decline to 0.11. In addition to that, Price Earnings Ratio is expected to decline to -3.23. Immunoprecise Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 3rd of January 2017 | 200 Day MA 1.0134 | 50 Day MA 0.5345 | Beta 0.273 |
Immunoprecise |
Sharpe Ratio = -0.1108
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IPA |
Estimated Market Risk
| 6.68 actual daily | 59 59% of assets are less volatile |
Expected Return
| -0.74 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Immunoprecise Antibodies is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immunoprecise Antibodies by adding Immunoprecise Antibodies to a well-diversified portfolio.
Price Book 0.5049 | Enterprise Value Ebitda (4.68) | Price Sales 0.4883 | Shares Float 24.5 M | Wall Street Target Price 6 |
Related Headline
Recursion Pharmaceuticals Headline on 11th of September 2024
Disposition of 375 shares by Michael Secora of Recursion Pha... by Michael Secora
Filed transaction by Recursion Pharmaceuticals Officer: Chief Financial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Immunoprecise Antibodies Valuation on September 11, 2024
It is possible to determine the worth of Immunoprecise Antibodies on a given historical date. On September 11, 2024 Immunoprecise was worth 0.66 at the beginning of the trading date compared to the closed value of 0.64. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Immunoprecise Antibodies stock. Still, in general, we apply an absolute valuation method to find Immunoprecise Antibodies' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Immunoprecise Antibodies where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Immunoprecise Antibodies' related companies.
| Open | High | Low | Close | Volume | |
| 0.66 | 0.68 | 0.63 | 0.66 | 237,307 | |
09/11/2024 | 0.66 | 0.68 | 0.64 | 0.64 | 110,406 |
| 0.64 | 0.67 | 0.62 | 0.64 | 146,343 |
| Backtest Immunoprecise Antibodies | | | Immunoprecise Antibodies History | | | Immunoprecise Antibodies Valuation | Previous | Next |
Immunoprecise Antibodies Trading Date Momentum on September 11, 2024
| On September 12 2024 Immunoprecise Antibodies was traded for 0.64 at the closing time. Highest Immunoprecise Antibodies's price during the trading hours was 0.67 and the lowest price during the day was 0.62 . The net volume was 146.3 K. The overall trading history on the 12th of September 2024 did not cause price change. The trading delta at closing time to current price is 4.69% . |
Immunoprecise Antibodies Fundamentals Correlations and Trends
By evaluating Immunoprecise Antibodies' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Immunoprecise Antibodies' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Immunoprecise financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Immunoprecise Antibodies Stock history
Immunoprecise Antibodies investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Immunoprecise is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Immunoprecise Antibodies will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Immunoprecise Antibodies stock prices may prove useful in developing a viable investing in Immunoprecise Antibodies
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 25.6 M | 26.9 M | |
| Net Loss | -23.9 M | -22.7 M |
Immunoprecise Antibodies Stock Technical Analysis
Immunoprecise Antibodies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Immunoprecise Antibodies Period Price Range
Low | November 27, 2024
| High |
0.00 | 0.00 |
Immunoprecise Antibodies cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Immunoprecise Antibodies November 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Immunoprecise Antibodies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Immunoprecise Antibodies shares will generate the highest return on investment. By undertsting and applying Immunoprecise Antibodies stock market strength indicators, traders can identify Immunoprecise Antibodies entry and exit signals to maximize returns
Immunoprecise Antibodies Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Immunoprecise Antibodies' price direction in advance. Along with the technical and fundamental analysis of Immunoprecise Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Immunoprecise to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.63) | |||
| Total Risk Alpha | (1.82) | |||
| Treynor Ratio | 0.6099 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Immunoprecise Stock analysis
When running Immunoprecise Antibodies' price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |